Testing effectiveness (Phase 2)Study completedNCT01874873What this trial is testingA Phase II Study of Anlotinib in MTC PatientsWho this might be right forTumor Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 58
Not applicableActive Not RecruitingNCT07259304What this trial is testingSocial Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+97 more University of Southern California 118
Early research (Phase 1)Study completedNCT00005647What this trial is testingSU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckWho this might be right forHead and Neck Cancer Case Comprehensive Cancer Center 12
Early research (Phase 1)Study completedNCT00098943What this trial is testingNGR-TNF in Treating Patients With Advanced Solid TumorsWho this might be right forColorectal CancerHead and Neck CancerKidney Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Study completedNCT03037385What this trial is testingPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more Hoffmann-La Roche 590
Testing effectiveness (Phase 2)Study completedNCT00519896What this trial is testingSunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerWho this might be right forRecurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+5 more University of Washington 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07816770What this trial is testingMANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary CarcinomasWho this might be right forMetastatic Non-Clear Cell Renal Cell CarcinomaMetastatic Renal Medullary Carcinomas Fudan University 30
Testing effectiveness (Phase 2)Ended earlyNCT00582712What this trial is testingAn Initial Study of Lithium in Patients With Medullary Thyroid CancerWho this might be right forMedullary Thyroid Cancer University of Wisconsin, Madison 5
Not applicableStudy completedNCT03774862What this trial is testingClinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort StudyWho this might be right forColorectal Medullary Carcinoma V.K.V. American Hospital, Istanbul 13
Early research (Phase 1)Study completedNCT01709435What this trial is testingCabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsWho this might be right forRecurrent Malignant Solid NeoplasmRecurrent MelanomaRecurrent Primary Central Nervous System Neoplasm+4 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792What this trial is testingOral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsWho this might be right forMedullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more Eli Lilly and Company 36
Not applicableStudy completedNCT05184153What this trial is testingMedullary Colonic CarcinomaWho this might be right forMedullary Carcinoma of ColonPrognostic FactorsSurvival Analysis University Hospital, Limoges 10
Not applicableStudy completedNCT02109250What this trial is testingCAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical PracticeWho this might be right forMetastatic Medullary Thyroid Cancer Genzyme, a Sanofi Company 10
Not applicableLooking for participantsNCT07138716What this trial is testingResearch on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTCWho this might be right forMedullary Thyroid Carcinoma Luo Yaping 30
Testing effectiveness (Phase 2)Study completedNCT01164176What this trial is testingEverolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerWho this might be right forHead and Neck Cancer Yonsei University 40
Early research (Phase 1)Not Yet RecruitingNCT07252661What this trial is testingStudy of ACC-1898 in Adult Participants With Advanced Solid TumorsWho this might be right forHepatocellular CarcinomaRenal Cell CarcinomaThyroid Carcinoma, Medullary+6 more AccSalus Biosciences, Inc. 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04211337What this trial is testingSelpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid CancerWho this might be right forMedullary Thyroid Cancer Loxo Oncology, Inc. 291
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280081What this trial is testingSelpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET ActivationWho this might be right forSolid TumorMedullary Thyroid Cancer Eli Lilly and Company 77
Early research (Phase 1)Ended earlyNCT05355753What this trial is testingAssess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null TumorsWho this might be right forSynovial SarcomaSoft Tissue Sarcoma C4 Therapeutics, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT00514046What this trial is testingVandetanib to Treat Children and Adolescents With Medullary Thyroid CancerWho this might be right forMedullary Thyroid CarcinomaMultiple Endocrine Neoplasia Type 2AMultiple Endocrine Neoplasia Type 2B National Cancer Institute (NCI) 17